Tag: AI

Collaboration on Developing First-in-Class Therapeutics for NSCLC

SK Biopharmaceuticals, a pharmaceutical company focused on disorders of central nervous system and cancer, and twoXAR, Inc., an artificial intelligence (AI)-driven biopharmaceutical company, announced...

Bayer Expands Digital Health Focus

bayer
 Collaboration programs are being combined and longer-term oriented. As a pioneer when it comes to collaborating with digital health start-ups, Bayer is now taking the next step. Instead of one-off...

Exscientia Establishes Subsidiary for Expanding in Asia

Exscientia, the world-leading Artificial Intelligence (AI)-driven drug discovery company announces the establishment of a subsidiary, Exscientia K.K to spearhead its pharmaceutical interests across As...

Celgene Partners with AI Drug Discovery Company

Exscientia, a world-leading Artificial Intelligence (AI)-driven drug discovery company, announced today that it has entered a three-year AI drug discovery partnership with leading biopharma company Ce...

Ono Pharmaceutical and twoXAR in R&D Collaboration

Ono Pharmaceutical Co., Ltd., a Japanese pharmaceutical research and development company, and twoXAR, Inc., an artificial intelligence (AI)-driven biopharmaceutical company, announced today that the c...

Merck in Agreement for Using Iktos’ AI Technology

Agreement is part of Merck’s R&D strategy to advance drug discovery with strategic technology-focused collaborations. Merck, a leading science and technology company, announced a collaboration ...

Young Russian Scientist Invited New Alzheimer’s Diagnostic Way

Alzheimer's disease is a neurological disorder in which the death of brain cells causes memory loss and cognitive decline. A special device with artificial intelligence able to predict it has been inv...

US Alliance for Launching Prostate Cancer Confirmation Test

Anixa Biosciences, Inc., a biotechnology company focused on using the body's immune system to fight cancer, announced that it has entered into a strategic alliance with ResearchDx to launch its Cchek™...

PPD and HLT of China in Exclusive Agreement

Pharmaceutical Product Development, LLC (PPD) and Happy Life Tech (HLT) of China have signed an exclusive agreement to develop a distinctive service offering for the China drug-development market deli...

AI Drugs Should Be Regulated Better

Products based on artificial intelligence should be regulated like drugs, and those that are deemed unsafe should be removed from the market, according to a new report. The report commissioned by N...

Origenis and Expansion Therapeutics Unite for Molecule Research

Origenis announced today it has entered into a global license and collaboration agreement with Expansion Therapeutics to research and discover small molecule compounds targeting RNA-mediated diseases....

Novartis and Oxford University Join Forces for 5-Year Research

Novartis and Oxford University have begun a partnership that will attempt to use artificial intelligence to predict how patients will respond to new and existing treatments for inflammatory diseases s...

Collaboration of Japanese Companies in AI Drug R&D

Artificial intelligence and machine learning company InveniAI has joined with Kyowa Hakko Kirin to harness the power of technology for drug discovery. The companies are the latest to use AI and mac...

Elevian and Insilico to Discover Anti-Aging Drugs

Elevian and Insilico Medicine have announced a research and development partnership to develop oral medications targeting the GDF11 pathway and associated targets. Elevian is an emerging biotech co...

FDA’s Plans for Digital Therapeutics

The FDA has announced further details about its plans to hasten development of digital health products and tools. Pear Therapeutics in 2017 became the first company to get a “digital therapeutic” a...

Fast Track for Neurological and Psychiatric Diseases Drug

The FDA has granted Fast Track Designation to BioXcel Therapeutics’ BXCL501 for the treatment of acute agitation resulting from neurological and psychiatric disorders like Alzheimer’s and schizophreni...